ARCHIMED’s Post

Since ICON plc was founded in Dublin in 1990, the company has made over 30 acquisitions domestically and internationally and today operates in over 53 countries.  "The clinical trial industry has always been an environment that necessitates flexibility, consistency, creativity and simplicity; and ICON’s IT organisation is continually tasked with meeting these changing needs." THOMAS N O'LEARY, CIO, ICON PLc discusses the phenomenal growth at ICON, how the IT organisation supports large and complex integration projects and the importance of flexible digital infrastructure in enabling innovation, collaboration and meeting the unique requirements of clinical research.  Find out more about Tom's conversation with Peter Lantry via the link below Business & Finance Media Group

Achieving tangible growth for our clients is at the heart of what we do at https://hubs.li/Q026Z1Rv0. One of our start-up partners, The Smile Company, acquired 400 new patients in a mere three months. Our commitment to regular communication and transparent reporting through our real-time dashboard ensures our partners are always informed. Discover our approach and see how we can contribute to your practice's success. Learn more about our proven 5-C Method here: https://hubs.li/Q026Z0WK0 #ClientSuccessStory #DigitalMarketingInsights #TransparentReporting

DSS, Inc. (NYSE American: DSS) is proud to announce that it has officially filed a registration statement on Form S-1 for the IPO spin-off of Impact Biomedical, a human healthcare and wellness company and wholly-owned subsidiary of DSS, Inc. “The filing of the S-1 for the IPO of Impact Biomedical is a significant milestone towards DSS’s overall business plan of periodically spinning off valuable subsidiaries into separately traded companies.” -Jason Grady, COO of DSS, Inc. Learn more here → https://yhoo.it/3SaqCQI #DSSInc #ImpactBiomedical #BiotechnologyInvestment #InnovativeHealthSollutions #InvestmentstoWatch

DSS, Inc. (NYSE American: DSS) is proud to announce that it has officially filed a registration statement on Form S-1 for the IPO spin-off of Impact Biomedical, a human healthcare and wellness company and wholly-owned subsidiary of DSS, Inc. “The filing of the S-1 for the IPO of Impact Biomedical is a significant milestone towards DSS’s overall business plan of periodically spinning off valuable subsidiaries into separately traded companies.” -Jason Grady, COO of DSS, Inc. Learn more here → https://yhoo.it/3SaqCQI #DSSInc #ImpactBiomedical #BiotechnologyInvestment #InnovativeHealthSollutions #InvestmentstoWatch

SPAC Feed: SANUWAVE Health Combining with SEP Acquisition in $127.5M Deal - https://lnkd.in/eXVRH2hX SANUWAVE Health today announced a business combination with SEP Acquisition at an enterprise value of $127.5 million. SANUWAVE develops next-generation… #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic

Start the move from the reactive to the proactive in 2024!

Daniel Sheppard and Dave Sheppard, CMAA from @ MedWorld Advisors are at the Association for Corporate Growth (ACG) #DealMax24 today thru Wednesday. Looking forward to meeting with some of the most active PE Firms in Healthcare in 2024 on behalf of our clients. If your business is in #MedTech, #DigitalHealthTech, #Diagnostics, #LifeSciences, #DentalTech and you are thinking of selling (or someone you know is considering it), please feel free to reach out to discuss #Exit Strategy and #Valuation in today's marketplace. #mergersandacquisitions #M&A #medworld #exitstrategy

In a striking counter to the market's downtrend, #CapitolHealth Ltd's shares leapt by 20% post a takeover bid from Integral Diagnostics Ltd, making headlines in the diagnostic imaging services sector. 📈🏥 This bold move saw #CapitolHealth's shares climb to 29.5 cents, indicating a seismic shift in the market, propelled by a bid that values the company's shares at a 33% premium to the prior close. 💡 Key insights: - A scheme of arrangement is in place for 100% acquisition. - Shareholders could see significant value addition thanks to the enhanced growth and capabilities of the combined entities. The endorsement of the takeover by Capitol Health's management underscores the potential for nurturing market relevance through strategic partnerships.✨ This isn't just about a rise in shares—it's about setting a new competitive standard in Australia's healthcare sector and perhaps, a new chapter in quality service provision. Shareholders, brace for a transformative journey ahead. For more insights into what this means for the #HealthcareIndustry, read on: https://lnkd.in/g3j8SDpJ #MergersAndAcquisitions #HealthcareSector #MarketWatch #TakeoverBid #StrategicAlliances

OPTIMISM! Optimism! OPTIMISM! actually one point two billion data points of OPTIMISM, KEEPING YOUR EYES OPEN? I did ask you to and expect MOREin24! Opportunity grows with the OPTIMISM! With our eyes open we will be first to act on the growing opportunities! # commercial real estate

Read the MedTech Strategies LLC article below about our most recent event on healthcare's current (and future) financing trends. Don't miss Gabriele Brambilla's suggestions for the new year: 1) Watch for microeconomic trends to see what might affect your pathway. 2) Be creative and use different channels to develop relationships and adjust your approach. 3) Focus on clinical evidence and patient impact that might come through a clinical pathway other than 510k. 4) And of course, never give up!